erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
. would identify hospitals that are best positioned to treat strokes and establish protocols for emergency responders handling stroke patients.
.
.
.
.
.
.
"if the battery in a mechanical mod over-discharges and the device doesn't contain enough air holes to allow the battery to vent, there is a risk of explosion."
.
.
.
.